[go: up one dir, main page]

SE8403630D0 - Humana proteiner - Google Patents

Humana proteiner

Info

Publication number
SE8403630D0
SE8403630D0 SE8403630A SE8403630A SE8403630D0 SE 8403630 D0 SE8403630 D0 SE 8403630D0 SE 8403630 A SE8403630 A SE 8403630A SE 8403630 A SE8403630 A SE 8403630A SE 8403630 D0 SE8403630 D0 SE 8403630D0
Authority
SE
Sweden
Prior art keywords
proteins
antisera
humana
methods
determinatoin
Prior art date
Application number
SE8403630A
Other languages
English (en)
Other versions
SE500219C2 (sv
SE8403630L (sv
Inventor
M Fagerhol
I Dale
I Naesgaard
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8403630D0 publication Critical patent/SE8403630D0/sv
Publication of SE8403630L publication Critical patent/SE8403630L/sv
Publication of SE500219C2 publication Critical patent/SE500219C2/sv

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE8403630A 1983-07-11 1984-07-09 Humana granulocytproteiner SE500219C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838318754A GB8318754D0 (en) 1983-07-11 1983-07-11 Human proteins anti-sera test kits

Publications (3)

Publication Number Publication Date
SE8403630D0 true SE8403630D0 (sv) 1984-07-09
SE8403630L SE8403630L (sv) 1985-01-12
SE500219C2 SE500219C2 (sv) 1994-05-09

Family

ID=10545560

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403630A SE500219C2 (sv) 1983-07-11 1984-07-09 Humana granulocytproteiner

Country Status (11)

Country Link
US (1) US4833074A (sv)
JP (2) JPH0784479B2 (sv)
BE (1) BE900119A (sv)
CH (1) CH661048A5 (sv)
DE (1) DE3425186C2 (sv)
DK (1) DK169439B1 (sv)
FR (1) FR2550205B1 (sv)
GB (2) GB8318754D0 (sv)
IT (1) IT1177889B (sv)
NL (1) NL192456C (sv)
SE (1) SE500219C2 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5776348A (en) * 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
ATE278964T1 (de) 1996-11-01 2004-10-15 Magne K Fagerhol Verfahren zur proteinextraktion
ZA981370B (en) * 1997-02-20 1998-09-07 Cerberus Developments Bv Method and apparatus for continuous flow isoelectric focusing for purifying biological substances
EP1100828B1 (en) * 1998-07-22 2008-04-16 Sapporo Breweries Ltd. Methods for making antibodies against beer spoilage lactic acid bacteria and their diagnostic use
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
DE602004017148D1 (de) 2003-03-28 2008-11-27 Univ Laval S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
KR20070051287A (ko) * 2004-07-23 2007-05-17 아스펜바이오 팜, 인코퍼레이션. 맹장염 진단 방법 및 장치
EP2352762A1 (en) * 2008-11-03 2011-08-10 Schering Corporation Inflammatory bowel disease biomarkers and related methods of treatment
CN103025757A (zh) * 2010-04-29 2013-04-03 巴克斯特国际有限公司 二价阳离子结合蛋白在阴离子交换树脂上的纯化方法
JP6909208B2 (ja) 2015-09-17 2021-07-28 アムジェン インコーポレイテッド Il23経路バイオマーカーを使用するil23アンタゴニストに対する臨床応答の予測
JP2019508370A (ja) 2015-12-22 2019-03-28 アムジェン インコーポレイテッド Il23アンタゴニストに対する臨床応答の予測因子としてのccl20
BR112019023210A2 (pt) 2017-05-09 2020-05-26 Immundiagnostik Ag Método para determinação de membros da família s100 de proteínas de ligação ao cálcio por meio de imunoturbidimetria

Also Published As

Publication number Publication date
IT8448540A0 (it) 1984-07-10
GB8417338D0 (en) 1984-08-08
BE900119A (fr) 1985-01-09
CH661048A5 (de) 1987-06-30
NL192456C (nl) 1997-08-04
JP2558442B2 (ja) 1996-11-27
GB8318754D0 (en) 1983-08-10
DK338484A (da) 1985-01-12
NL8402182A (nl) 1985-02-01
IT1177889B (it) 1987-08-26
GB2143239B (en) 1987-11-11
JPH0784479B2 (ja) 1995-09-13
DK169439B1 (da) 1994-10-31
FR2550205B1 (fr) 1989-12-08
NL192456B (nl) 1997-04-01
GB2143239A (en) 1985-02-06
DK338484D0 (da) 1984-07-10
US4833074A (en) 1989-05-23
DE3425186A1 (de) 1985-01-24
SE500219C2 (sv) 1994-05-09
SE8403630L (sv) 1985-01-12
JPS6051113A (ja) 1985-03-22
DE3425186C2 (de) 1995-04-20
JPH07278194A (ja) 1995-10-24
FR2550205A1 (fr) 1985-02-08

Similar Documents

Publication Publication Date Title
SE8403630D0 (sv) Humana proteiner
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
PT804196E (pt) Utilizacao de antagonistas de serotonina (5ht3) para o tratamento de fibromialgia
ES529698A0 (es) Procedimiento para la produccion de proteinas correlacionadas con la toxina difterica
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
ES519944A0 (es) Procedimiento para la preparacion de proteinas succiniladas que contienen hierro.
NO851928L (no) Fremgangsmaate til fremstilling av glyserofosfocholin- og glyserofosfoetanolaminderivater og anvendelse derav.
AR221174A1 (es) Procedimiento para la descarbonatacion de gases
IT8019095A0 (it) Procedimento e installazione per la fabbricazione di clincher di cementeria.
ES492821A0 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxipiperidinas
ES492568A0 (es) Perfeccionamientos en la fabricacion de lamparas fluorescen-tes
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
ES492143A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
IT1163492B (it) Procedimento per la concia delle pelli
ES520599A0 (es) Procedimiento para la obtencion de fenoxipropiltriazolil-cetonas y carbinoles.
ES488301A0 (es) Procedimiento para la obtencion de dehidropeptidos
ES534551A0 (es) Procedimiento para la fabricacion de tarjetas de identificacion plastificadas
ATE98491T1 (de) Verwendung von antigestagenen zur herstellung von arzneimitteln.
ES537117A0 (es) Procedimiento para la fabricacion de bancos de hormigon
ES532015A0 (es) Procedimiento para la obtencion de fenoxitriazolil-cetonas y carbinoles
ES502033A0 (es) Procedimiento para la obtencion de imidazolil-indeno-tiofe- nos
AR228572A1 (es) Procedimiento para la preparacion de compuestos de organoestano,que contienen azufre en su molecula
RO86838A2 (ro) Compozitie pentru impermeabilizarea tesaturilor
IT1169177B (it) Procedimento per l'esecuzione di manufatti nel sottosuolo, in particolare di diaframmi

Legal Events

Date Code Title Description
NUG Patent has lapsed